Y. Wang, M. Yuan, Q. Y. Guo, S. B. Lu, and J. Peng, Mesenchymal stem cells for treating articular cartilage defects and osteoarthritis, Cell Transplant, 2014.

M. Gore, K. S. Tai, A. Sadosky, D. Leslie, and B. R. Stacey, Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis, J Med Econ, vol.14, pp.497-507, 2011.

B. Kristjansson and S. Honsawek, Current perspectives in mesenchymal stem cell therapies for osteoarthritis, Stem Cells Int, 2014.

F. J. Blanco, C. Ruiz-romero, and . Osteoarthritis, Metabolomic characterization of metabolic phenotypes in OA, Nat Rev Rheumatol, vol.8, pp.130-132, 2012.

J. Bondeson, S. D. Wainwright, S. Lauder, N. Amos, and C. E. Hughes, The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis, Arthritis Res Ther, vol.8, p.187, 2006.

J. Sellam and F. Berenbaum, The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis, Nat Rev Rheumatol, vol.6, pp.625-635, 2010.

I. Prasadam, R. Crawford, and Y. Xiao, Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes --possible pathogenic role in osteoarthritis, J Rheumatol, vol.39, pp.621-634, 2012.

G. Zhen, C. Wen, and X. Jia, Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis, Nat Med, vol.19, pp.704-712, 2013.

M. B. Goldring, Update on the biology of the chondrocyte and new approaches to treating cartilage diseases, Best Pract Res Clin Rheumatol, vol.20, pp.1003-1025, 2006.

P. S. Burrage, K. S. Mix, and C. E. Brinckerhoff, Matrix metalloproteinases: role in arthritis, Front Biosci, vol.11, pp.529-543, 2006.

J. W. Bijlsma, F. Berenbaum, and F. P. Lafeber, Osteoarthritis: an update with relevance for clinical practice, Lancet, vol.377, pp.2115-2126, 2011.

M. C. Hochberg, R. D. Altman, and K. T. April, American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee, Arthritis Care Res (Hoboken), vol.64, pp.465-474, 2012.

K. Mithoefer, T. Mcadams, R. J. Williams, P. C. Kreuz, and B. R. Mandelbaum, Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis, Am J Sports Med, vol.37, pp.2053-2063, 2009.

X. Chevalier, P. Goupille, and A. D. Beaulieu, Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebocontrolled study, Arthritis Rheum, vol.61, pp.344-352, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00618719

X. Chevalier, P. Ravaud, and E. Maheu, Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial, Ann Rheum Dis, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01451416

J. Ringe, G. R. Burmester, and M. Sittinger, Regenerative medicine in rheumatic disease-progress in tissue engineering, Nat Rev Rheumatol, vol.8, pp.493-498, 2012.

L. Moroni and P. M. Fornasari, Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues, J Cell Physiol, vol.228, pp.680-687, 2012.

P. Bianco, Mesenchymal" stem cells, Annu Rev Cell Dev Biol, vol.30, pp.677-704, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00465969

M. Dominici, L. Blanc, K. Mueller, and I. , Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, pp.315-317, 2006.

P. Bianco, Stem cells and bone: a historical perspective, Bone, vol.70, pp.2-9, 2015.

M. Maumus, C. Jorgensen, and D. Noel, Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes, Biochimie, vol.95, pp.2229-2234, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00832507

M. Lda, S. Fontes, A. M. Covas, D. T. Caplan, and A. I. , Mechanisms involved in the therapeutic properties of mesenchymal stem cells, Cytokine Growth Factor Rev, vol.20, pp.419-427, 2009.

D. C. De-almeida, C. Donizetti-oliveira, P. Barbosa-costa, C. S. Origassa, and N. O. Camara, In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury, Clin Biochem Rev, vol.34, pp.131-144, 2013.

S. Ghannam, C. Bouffi, F. Djouad, C. Jorgensen, and D. Noel, Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications, Stem Cell Res Ther, vol.1, issue.2, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-01878105

M. Krampera, J. Galipeau, Y. Shi, K. Tarte, and L. Sensebe, Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal, Cytotherapy, vol.15, pp.1054-1061, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00866729

B. Gyorgy, M. E. Hung, X. O. Breakefield, and J. N. Leonard, Therapeutic applications of extracellular vesicles: clinical promise and open questions, Annu Rev Pharmacol Toxicol, vol.55, pp.439-464, 2015.

R. C. Lai, R. W. Yeo, and S. K. Lim, Mesenchymal stem cell exosomes, Semin Cell Dev Biol, vol.40, pp.82-88, 2015.

P. Penfornis, K. C. Vallabhaneni, J. Whitt, and R. Pochampally, Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment, Int J Cancer, 2015.

C. Akyurekli, Y. Le, R. B. Richardson, D. Fergusson, J. Tay et al., A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles, Stem Cell Rev, vol.11, pp.150-160, 2015.

T. Kato, S. Miyaki, and H. Ishitobi, Exosomes from IL-1beta stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes, Arthritis Res Ther, vol.16, p.163, 2014.

S. Bruno, M. C. Deregibus, and G. Camussi, The secretome of mesenchymal stromal cells: Role of extracellular vesicles in immunomodulation, Immunol Lett, 2015.

A. Mokarizadeh, N. Delirezh, A. Morshedi, G. Mosayebi, A. A. Farshid et al., Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling, Immunol Lett, vol.147, pp.47-54, 2012.

R. Blazquez, F. M. Sanchez-margallo, and O. De-la-rosa, Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol, vol.5, p.556, 2014.

B. Zhang, Y. Yin, R. C. Lai, S. S. Tan, A. B. Choo et al., Mesenchymal stem cells secrete immunologically active exosomes, Stem Cells Dev, vol.23, pp.1233-1244, 2014.

M. Budoni, A. Fierabracci, R. Luciano, S. Petrini, D. Ciommo et al., The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles, Cell Transplant, vol.22, pp.369-379, 2013.

S. Bian, L. Zhang, L. Duan, X. Wang, Y. Min et al., Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model, J Mol Med (Berl), vol.92, pp.387-397, 2014.

Y. Zhou, H. Xu, and W. Xu, Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro, Stem Cell Res Ther, vol.4, p.34, 2013.

S. Bruno, C. Grange, and M. C. Deregibus, Mesenchymal stem cell-derived microvesicles protect against acute tubular injury, J Am Soc Nephrol, vol.20, pp.1053-1067, 2009.

T. Li, Y. Yan, and B. Wang, Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis, Stem Cells Dev, vol.22, pp.845-854, 2013.

C. Lee, S. A. Mitsialis, and M. Aslam, Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension, Circulation, vol.126, pp.2601-2611, 2012.

H. Xin, Y. Li, and B. Buller, Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth, Stem Cells, vol.30, pp.1556-1564, 2012.

C. Vinatier, C. Bouffi, and C. Merceron, Cartilage engineering: Towards a biomaterial-assisted mesenchymal stem cell therapy, Curr Stem Cell Res Ther, vol.4, pp.318-329, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00423696

M. Demoor, D. Ollitrault, and T. Gomez-leduc, Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction, Biochim Biophys Acta, vol.1840, pp.2414-2440, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02132064

Q. Li, J. Tang, and R. Wang, Comparing the chondrogenic potential in vivo of autogeneic mesenchymal stem cells derived from different tissues, Artif Cells Blood Substit Immobil Biotechnol, vol.39, pp.31-38, 2010.

Y. Ogata, Y. Mabuchi, and M. Yoshida, Purified Human Synovium Mesenchymal Stem Cells as a Good Resource for Cartilage Regeneration, PLoS One, vol.10, p.129096, 2015.

K. C. Russell, D. G. Phinney, M. R. Lacey, B. L. Barrilleaux, K. E. Meyertholen et al., In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment, Stem Cells, vol.28, pp.788-798, 2010.

J. M. Murphy, K. Dixon, S. Beck, D. Fabian, A. Feldman et al., Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis, Arthritis Rheum, vol.46, pp.704-713, 2002.

A. Scharstuhl, B. Schewe, K. Benz, C. Gaissmaier, H. J. Buhring et al., Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology, Stem Cells, vol.25, pp.3244-3251, 2007.

V. Dudics, A. Kunstar, and J. Kovacs, Chondrogenic potential of mesenchymal stem cells from patients with rheumatoid arthritis and osteoarthritis: measurements in a microculture system, Cells Tissues Organs, vol.189, pp.307-316, 2009.

J. O'sullivan, D. 'arcy, S. Barry, F. P. Murphy, J. M. Coleman et al., Mesenchymal chondroprogenitor cell origin and therapeutic potential, Stem Cell Res Ther, vol.2, issue.8, 2011.

S. Grassel and J. Lorenz, Tissue-engineering strategies to repair chondral and osteochondral tissue in osteoarthritis: use of mesenchymal stem cells, Curr Rheumatol Rep, vol.16, p.452, 2014.

D. Mrugala, C. Bony, and N. Neves, Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model, Ann Rheum Dis, vol.67, pp.288-295, 2008.

B. Marquass, R. Schulz, and P. Hepp, Matrix-associated implantation of predifferentiated mesenchymal stem cells versus articular chondrocytes: in vivo results of cartilage repair after 1 year, Am J Sports Med, vol.39, pp.1401-1412, 2011.

B. Marquass, J. S. Somerson, and P. Hepp, A novel MSC-seeded triphasic construct for the repair of osteochondral defects, J Orthop Res, vol.28, pp.1586-1599, 2010.

J. P. Seo, T. Tanabe, and N. Tsuzuki, Effects of bilayer gelatin/beta-tricalcium phosphate sponges loaded with mesenchymal stem cells, chondrocytes, bone morphogenetic protein-2, and platelet rich plasma on osteochondral defects of the talus in horses, Res Vet Sci, vol.95, pp.1210-1216, 2013.

M. Brittberg, A. Lindahl, A. Nilsson, C. Ohlsson, O. Isaksson et al., Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation, N Engl J Med, vol.331, pp.889-895, 1994.

A. P. Hollander, S. C. Dickinson, and T. J. Sims, Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees, Tissue Eng, vol.12, pp.1787-1798, 2006.

P. C. Kreuz, S. Muller, C. Ossendorf, C. Kaps, and C. Erggelet, Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results, Arthritis Res Ther, vol.11, p.33, 2009.

S. Wakitani, T. Goto, and S. J. Pineda, Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage, J Bone Joint Surg Am, vol.76, pp.579-592, 1994.

S. Wakitani, T. Okabe, and S. Horibe, Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months, J Tissue Eng Regen Med, vol.5, pp.146-150, 2011.

H. Nejadnik, J. H. Hui, F. Choong, E. P. Tai, B. C. Lee et al., Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study, Am J Sports Med, vol.38, pp.1110-1116, 2010.

A. M. Haleem, A. A. Singergy, and D. Sabry, The Clinical Use of Human CultureExpanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results, Cartilage, vol.1, pp.253-261, 2010.

C. Kasemkijwattana, S. Hongeng, S. Kesprayura, V. Rungsinaporn, K. Chaipinyo et al., Autologous bone marrow mesenchymal stem cells implantation for cartilage defects: two cases report, J Med Assoc Thai, vol.94, pp.395-400, 2011.

I. Akgun, M. C. Unlu, and O. A. Erdal, Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study, Arch Orthop Trauma Surg, vol.135, pp.251-263, 2015.

L. Wu, J. C. Leijten, N. Georgi, J. N. Post, C. A. Van-blitterswijk et al., Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation, Tissue Eng Part A, vol.17, pp.1425-1436, 2011.

L. Wu, H. J. Prins, M. N. Helder, C. A. Van-blitterswijk, and M. Karperien, Trophic Effects of Mesenchymal Stem Cells in Chondrocyte Co-Cultures are Independent of Culture Conditions and Cell Sources, Tissue Eng Part A, vol.18, pp.1542-1551, 2012.

M. Wang, R. Rahnama, and T. Cheng, Trophic stimulation of articular chondrocytes by late-passage mesenchymal stem cells in coculture, J Orthop Res, vol.31, pp.1936-1942, 2013.

C. S. Lee, O. A. Burnsed, V. Raghuram, J. Kalisvaart, B. D. Boyan et al., Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration, Stem Cell Res Ther, vol.3, p.35, 2012.

L. Xu, Q. Wang, F. Xu, Z. Ye, Y. Zhou et al., Mesenchymal stem cells downregulate articular chondrocyte differentiation in noncontact coculture systems: implications in cartilage tissue regeneration, Stem Cells Dev, vol.22, pp.1657-1669, 2013.

M. Maumus, C. Manferdini, and K. Toupet, Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis, Stem Cell Res, vol.11, pp.834-844, 2013.

C. Manferdini, M. Maumus, and E. Gabusi, Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin e2, Arthritis Rheum, vol.65, pp.1271-1281, 2013.

G. M. Van-buul, E. Villafuertes, and P. K. Bos, Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture, Osteoarthritis Cartilage, vol.20, pp.1186-1196, 2012.

W. S. Toh, C. B. Foldager, M. Pei, and J. H. Hui, Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration, Stem Cell Rev, vol.10, pp.686-696, 2014.

J. M. Murphy, D. J. Fink, E. B. Hunziker, and F. P. Barry, Stem cell therapy in a caprine model of osteoarthritis, Arthritis Rheum, vol.48, pp.3464-3474, 2003.

F. Barry and M. Murphy, Mesenchymal stem cells in joint disease and repair, Nat Rev Rheumatol, vol.9, pp.584-594, 2013.

M. Ter-huurne, R. Schelbergen, and R. Blattes, Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis, Arthritis Rheum, vol.64, pp.3604-3613, 2012.

R. F. Schelbergen, S. Van-dalen, T. Huurne, and M. , Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels, Osteoarthritis Cartilage, vol.22, pp.1158-1166, 2014.

D. D. Frisbie, J. D. Kisiday, C. E. Kawcak, N. M. Werpy, and C. W. Mcilwraith, Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis, J Orthop Res, vol.27, pp.1675-1680, 2009.

K. Toupet, M. Maumus, and J. A. Peyrafitte, Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice, Arthritis Rheum, vol.65, pp.1786-1794, 2013.

K. Toupet, M. Maumus, L. , and P. , Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis, PLoS One, vol.10, p.114962, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01834412

C. J. Centeno, D. Busse, J. Kisiday, C. Keohan, M. Freeman et al., Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells, Pain Physician, vol.11, pp.343-353, 2008.

F. Davatchi, B. S. Abdollahi, M. Mohyeddin, F. Shahram, and B. Nikbin, Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients, Int J Rheum Dis, vol.14, pp.211-215, 2011.

M. Emadedin, N. Aghdami, and L. Taghiyar, Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis, Arch Iran Med, vol.15, pp.422-428, 2012.

F. Davatchi, B. Sadeghi-abdollahi, M. Mohyeddin, and B. Nikbin, Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients, Int J Rheum Dis, 2015.

C. J. Centeno, J. R. Schultz, M. Cheever, B. Robinson, M. Freeman et al., Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique, Curr Stem Cell Res Ther, vol.5, pp.81-93, 2010.

Y. G. Koh and Y. J. Choi, Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis, Knee, vol.19, pp.902-907, 2012.

Y. G. Koh, Y. J. Choi, O. R. Kwon, and Y. S. Kim, Second-Look Arthroscopic Evaluation of Cartilage Lesions After Mesenchymal Stem Cell Implantation in Osteoarthritic Knees, Am J Sports Med, vol.42, pp.1628-1637, 2014.

L. Orozco, A. Munar, and R. Soler, Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results, Transplantation, vol.97, pp.66-68, 2014.

M. Emadedin, G. Liastani, M. Fazeli, and R. , Long-Term Follow-up of Intra-articular Injection of Autologous Mesenchymal Stem Cells in Patients with Knee, Ankle, or Hip Osteoarthritis, Arch Iran Med, vol.18, pp.336-344, 2015.

K. L. Wong, K. B. Lee, B. C. Tai, P. Law, E. H. Lee et al., Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years' follow-up, Arthroscopy, vol.29, pp.2020-2028, 2013.

C. H. Jo, Y. G. Lee, and W. H. Shin, Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial, Stem Cells, vol.32, pp.1254-1266, 2014.

N. Arden, P. Richette, and C. Cooper, Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty, Drugs Aging, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01170402

P. K. Gupta, A. K. Das, A. Chullikana, and A. S. Majumdar, Mesenchymal stem cells for cartilage repair in osteoarthritis, Stem Cell Res Ther, vol.3, p.25, 2012.